EUVIMEDEUVIMED entdecken
Crossref

Chloroprocaine antagonizes progression of breast cancer by regulating LINC00494/miR‐3619‐5p/MED19 axis

Chen Chen, Ning Wang, Tingting Huang, Gao Cheng, Yuexia Hu, Bingjie Wang, Ye Zhang, Chunhui Wang

Journal of Biochemical and Molecular Toxicology · 2024

DOI: 10.1002/jbt.23524 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, 2024. Verfasst von Chen Chen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, The First Affifiliated Hospital of Anhui Medical University, Hefei, China. Hauptthemen laut MEDLINE: Breast Neoplasms, MicroRNAs. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: Basic and Clinical Cooperative Research Promotion Program of Anhui Medical University, Research Fund Project of Anhui Medical University, Open Research fund of Key Laboratory of Anesthesiology and Perioperative Medicine of Anhui Higher Education Institutes, Anhui Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast cancer, as the most prevalent female malignancy, leads the cancer‐related death in women worldwide. Local anesthetic chloroprocaine exhibits antitumor potential, but its specific functions and underlying molecular mechanisms in breast cancer remain unclear. Here, we demonstrated chloroprocaine significantly inhibited proliferation, invasion and induced apoptosis of breast cancer cells in vitro. Tumor growth and pulmonary metastasis were also suppressed in BABL/c nude mice model with chloroprocaine treatment. LINC00494 was identified as one of the most downregulated long noncoding RNAs in chloroprocaine‐treated breast cancer cells by high‐throughput sequencing. Futhermore, high level of LINC00494 was positively associated with poor outcome of breast cancer patients. LINC00494 acted as a “miRNAs sponge” to compete with MED19 for the biding of miR‐3619‐5p, led to the upregulation of MED19. LINC00494/miR‐3619‐5p/MED19 axis participated in chloroprocaine‐mediated inhibition of proliferation, invasion and promotion of apoptosis of breast cancer cells. Consequently, our finding suggested local anesthetic chloroprocaine attenuated breast cancer aggressiveness through LINC00494‐mediated signaling pathway, which detailly revealed the clinical value of chloroprocaine during breast cancer treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsMicroRNAsAnimalsMiceHumansFemaleMice, NudeAnesthetics, LocalCell Line, TumorCell ProliferationApoptosisGene Expression Regulation, NeoplasticCell MovementMediator ComplexProcaine

Stichwörter der Autor:innen

LINC00494MED19breast cancerchloroprocainemiR-3619-5p

Substanzen

chloroprocaineAnesthetics, LocalMicroRNAsMED19 protein, humanMediator ComplexMIRN-3619 microRNA, humanProcaine

Autor:innen und Institutionen

  • Department of Anesthesiology, The First Affifiliated Hospital of Anhui Medical University, Hefei, China.
  • Anhui Public Health Clinical Center, Hefei, China.
  • Department of Anesthesiology and Perioperative Medicine, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
  • Key Laboratory of Anesthesiology and Perioperative Medicine of Anhui Higher Education Institutes, Anhui Medical University, Hefei, Anhui, China.

Förderung

  • Basic and Clinical Cooperative Research Promotion Program of Anhui Medical University
  • Research Fund Project of Anhui Medical University
  • Open Research fund of Key Laboratory of Anesthesiology and Perioperative Medicine of Anhui Higher Education Institutes, Anhui Medical University
  • Anhui Medical University

Zitieren

APA

Chen, C., Wang, N., Huang, T., Cheng, G., Hu, Y., Wang, B., Zhang, Y., & Wang, C. (2024). Chloroprocaine antagonizes progression of breast cancer by regulating LINC00494/miR‐3619‐5p/MED19 axis. Journal of Biochemical and Molecular Toxicology. https://doi.org/10.1002/jbt.23524

Vancouver

Chen C, Wang N, Huang T, Cheng G, Hu Y, Wang B, et al. Chloroprocaine antagonizes progression of breast cancer by regulating LINC00494/miR‐3619‐5p/MED19 axis. Journal of Biochemical and Molecular Toxicology. 2024. doi:10.1002/jbt.23524

BibTeX
@article{Chen2024,
  author = {Chen, Chen and Wang, Ning and Huang, Tingting and Cheng, Gao and Hu, Yuexia and Wang, Bingjie and Zhang, Ye and Wang, Chunhui},
  title = {Chloroprocaine antagonizes progression of breast cancer by regulating LINC00494/miR‐3619‐5p/MED19 axis},
  journal = {Journal of Biochemical and Molecular Toxicology},
  year = {2024},
  doi = {10.1002/jbt.23524}
}
Kostenlos starten →